IRIS-PREMIER REGISTRY
IRIS-PREMIER
Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
1 other identifier
observational
2,006
1 country
25
Brief Summary
The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2014
Longer than P75 for all trials
25 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2014
CompletedFirst Posted
Study publicly available on registry
February 12, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedSeptember 13, 2021
September 1, 2021
2.8 years
February 10, 2014
September 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite event rate
Death, non fatal myocardial infarction, Target Vessel Revascularization
1year
Secondary Outcomes (10)
All death
5year
Cardiac death
5year
Myocardial infarction
5year
Composite event of death or myocardial infarction
5year
Composite event of cardiac death or myocardial infarction
5year
- +5 more secondary outcomes
Study Arms (1)
IRIS PREMIER Cohort
Promus PREMIER
Interventions
Eligibility Criteria
patients with Promus PREMIER stent
You may qualify if:
- Age 20 and more
- Intervention with Promus PREMIER everolimus eluting coronary stent
- Agreed with written informed consent form
You may not qualify if:
- Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
- Boston Scientific Korea Co. Ltdcollaborator
Study Sites (25)
Hallym University Sacred Heart Hospital
Anyang, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Chungbuk National University Hospital
Cheongju-si, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Yeungnam University Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Kwangju Christian Hospital
Kwangju, South Korea
Inje University Pusan Paik Hospital
Pusan, South Korea
Kosin University Hospital
Pusan, South Korea
Pusan National University Hospital
Pusan, South Korea
Asan Medical Hospital
Seoul, South Korea
Eulji General Hospital
Seoul, South Korea
Kangdong Sacred Heart Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Kyunghee University Medical Center
Seoul, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
The Catholic University of Korea St. Paul's Hospital
Seoul, South Korea
The Catholic University of Korea Uijeongbu St. Mary's Hospital
Uijeongbu-si, South Korea
Ulsan University Hospital
Ulsan, South Korea
Pusan National University Yangsan Hospital
Yangsan, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD,PhD
Study Record Dates
First Submitted
February 10, 2014
First Posted
February 12, 2014
Study Start
August 1, 2014
Primary Completion
June 1, 2017
Study Completion
June 1, 2021
Last Updated
September 13, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
This is not a publicly funded trial.